Latest Period
Q2 2026
Security Snapshot
AVITA Medical, Inc. - Common Stock (RCEL) Institutional Ownership
CUSIP: 05380C102
13F Institutional Holders and Ownership History from Q1 2019 to Q2 2026
Institutions Reporting
73
Shares (Excl. Options)
4,929,785
Price
$4.13
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- RCEL on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 4,929,785
- Total 13F value
- $20,360,520
- Portfolio coverage rank
- 0%
- Share change
- -897,757
- Value change
- -$3,328,125
- Number of holders
- 73
- Shares outstanding
- 30,540,782
- SEC-reported price per share
- $8.01
- Insider filing price
- $8.01
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- RCEL - AVITA Medical, Inc. - Common Stock is tracked under CUSIP 05380C102.
- 73 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 78 to 73 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $21,388,708 to $20,360,520.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 73 institutions filings for Q2 2026.
Security key
05380C102
Latest holder period
Q2 2026
13F holders
73
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
RCEL full holder history
AVITA Medical, Inc. SEC filings
AVITA Medical, Inc. company facts
AVITA Medical, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 05380C102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
RCEL
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 4.7% | $4,988,131 | 1,444,579 | The Vanguard Group | 31 Dec 2025 | |||
| BlackRock, Inc. | 4.3% | $5,816,042 | 1,138,436 | BlackRock, Inc. | 30 Sep 2025 |
As of 30 Jun 2026, 73 institutional investors reported holding 4,929,785 shares of AVITA Medical, Inc. - Common Stock (RCEL). This represents 16% of the company’s total 30,540,782 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
15%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 4.4% | 1,333,914 | -0.09% | 0% | $5,509,065 |
| BlackRock, Inc. | 1.8% | 564,952 | -50% | 0% | $2,333,251 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1% | 339,822 | -37% | 0% | $1,404,076 |
| MARSHALL WACE, LLP | 1.1% | 338,387 | +544% | 0% | $1,397,539 |
| AQR CAPITAL MANAGEMENT LLC | 1.1% | 321,013 | +240% | 0% | $1,325,784 |
| MORGAN STANLEY | 0.66% | 200,462 | +27% | 0% | $827,909 |
| VANGUARD FIDUCIARY TRUST CO | 0.6% | 182,402 | -5.7% | 0% | $753,320 |
| NewEdge Advisors, LLC | 0.49% | 148,931 | +71% | 0% | $615,085 |
| MACQUARIE GROUP LTD | 0.47% | 144,164 | +1111% | 0% | $595,395 |
| STATE STREET CORP | 0.42% | 128,977 | -70% | 0% | $532,675 |
| Quantinno Capital Management LP | 0.34% | 105,248 | +368% | 0% | $434,674 |
| Divisadero Street Capital Management, LP | 0.33% | 100,000 | 0% | 0.01% | $413,000 |
| UBS Group AG | 0.28% | 84,033 | +35% | 0% | $347,056 |
| GOLDMAN SACHS GROUP INC | 0.25% | 76,737 | -23% | 0% | $316,924 |
| NORTHERN TRUST CORP | 0.23% | 68,973 | -62% | 0% | $284,858 |
| Qube Research & Technologies Ltd | 0.21% | 63,784 | 0% | $263,428 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.2% | 60,746 | 0% | $250,881 | |
| XTX Topco Ltd | 0.19% | 57,161 | 0% | $236,075 | |
| BNP PARIBAS FINANCIAL MARKETS | 0.18% | 53,958 | 0% | 0% | $222,847 |
| BANK OF AMERICA CORP /DE/ | 0.17% | 51,667 | -17% | 0% | $213,384 |
| FMR LLC | 0.11% | 32,515 | +14% | 0% | $134,287 |
| IEQ CAPITAL, LLC | 0.11% | 32,400 | 0% | $133,812 | |
| THOMPSON DAVIS & CO., INC. | 0.1% | 31,090 | -20% | 0.08% | $128,402 |
| Jain Global LLC | 0.1% | 30,775 | 0% | $127,101 | |
| AMERIPRISE FINANCIAL INC | 0.09% | 29,013 | +0.9% | 0% | $119,823 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
30
Latest
Q2 2026
Rows shown
1-25 of 30
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 4,929,785 | $20,360,520 | -$3,328,125 | $4.13 | 73 |
| 2026 Q1 | 5,782,060 | $21,388,708 | +$2,933,889 | $3.70 | 78 |
| 2025 Q4 | 4,822,753 | $16,637,912 | -$1,664,392 | $3.45 | 67 |
| 2025 Q3 | 5,138,582 | $26,258,249 | -$13,168,452 | $5.11 | 75 |
| 2025 Q2 | 7,684,503 | $40,650,943 | +$2,876,263 | $5.29 | 79 |
| 2025 Q1 | 7,044,428 | $57,343,339 | +$2,375,906 | $8.14 | 74 |
| 2024 Q4 | 6,454,868 | $82,623,830 | +$4,559,187 | $12.80 | 72 |
| 2024 Q3 | 6,095,789 | $65,347,676 | +$515,283 | $10.72 | 67 |
| 2024 Q2 | 6,099,329 | $48,306,700 | -$15,647,217 | $7.92 | 68 |
| 2024 Q1 | 7,319,846 | $117,332,190 | +$4,381,511 | $16.03 | 81 |
| 2023 Q4 | 7,095,304 | $97,348,681 | -$14,976,745 | $13.72 | 83 |
| 2023 Q3 | 8,129,935 | $118,780,112 | +$7,346,625 | $14.61 | 80 |
| 2023 Q2 | 7,611,611 | $129,472,974 | +$30,265,942 | $17.01 | 80 |
| 2023 Q1 | 5,906,388 | $82,511,505 | +$21,157,921 | $13.97 | 72 |
| 2022 Q4 | 4,410,243 | $29,107,642 | +$1,258,474 | $6.60 | 51 |
| 2022 Q3 | 4,306,669 | $22,694,330 | -$3,509,090 | $5.27 | 42 |
| 2022 Q2 | 5,060,740 | $24,039,067 | -$9,600,413 | $4.75 | 48 |
| 2022 Q1 | 6,867,607 | $58,179,804 | -$8,054,352 | $8.48 | 65 |
| 2021 Q4 | 7,465,802 | $89,556,714 | -$12,879,940 | $11.98 | 59 |
| 2021 Q3 | 8,337,406 | $148,034,944 | -$7,922,344 | $17.72 | 67 |
| 2021 Q2 | 8,754,978 | $179,543,764 | +$37,847,379 | $20.52 | 69 |
| 2021 Q1 | 7,070,182 | $139,896,335 | +$55,735,706 | $19.82 | 59 |
| 2020 Q4 | 4,168,156 | $77,440,780 | +$11,413,265 | $18.58 | 49 |
| 2020 Q3 | 3,433,525 | $86,331,057 | +$50,603,668 | $25.16 | 40 |
| 2020 Q2 | 1,409,579 | $43,046,283 | +$43,046,283 | $30.53 | 31 |